3-hydroxy-2-(2-methyl-3-(4-methylbenzyloxy)benzoyl)cyclohex-2-en-1-one

ID: ALA4533367

PubChem CID: 155547485

Max Phase: Preclinical

Molecular Formula: C22H22O4

Molecular Weight: 350.41

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ccc(COc2cccc(C(=O)C3=C(O)CCCC3=O)c2C)cc1

Standard InChI:  InChI=1S/C22H22O4/c1-14-9-11-16(12-10-14)13-26-20-8-3-5-17(15(20)2)22(25)21-18(23)6-4-7-19(21)24/h3,5,8-12,23H,4,6-7,13H2,1-2H3

Standard InChI Key:  ZNLPMGHHESJSFQ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 26 28  0  0  0  0  0  0  0  0999 V2000
   20.8838  -20.7600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7219  -19.9551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7207  -20.7746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4288  -21.1836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1385  -20.7742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1356  -19.9515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4270  -19.5463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0141  -19.5467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0139  -18.7295    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.3065  -19.9555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5968  -19.5400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8913  -19.9453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5949  -21.1734    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3066  -20.7665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6002  -18.7228    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.0135  -21.1765    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.8418  -19.5403    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.5510  -19.9462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2572  -19.5349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9649  -19.9442    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6705  -19.5337    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6679  -18.7156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9537  -18.3099    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2509  -18.7228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3735  -18.3034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4246  -18.7291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  2  1  0
  2  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  2  0
 10 14  1  0
 11 12  1  0
 12  1  1  0
  1 13  1  0
 13 14  1  0
 11 15  1  0
 14 16  2  0
  6 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
 22 25  1  0
  7 26  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4533367

    ---

Associated Targets(Human)

HPD Tclin 4-hydroxyphenylpyruvate dioxygenase (117 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 350.41Molecular Weight (Monoisotopic): 350.1518AlogP: 4.63#Rotatable Bonds: 5
Polar Surface Area: 63.60Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 4.62CX Basic pKa: CX LogP: 4.59CX LogD: 1.88
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.63Np Likeness Score: -0.10

References

1. Ndikuryayo F, Kang WM, Wu FX, Yang WC, Yang GF..  (2019)  Hydrophobicity-oriented drug design (HODD) of new human 4-hydroxyphenylpyruvate dioxygenase inhibitors.,  166  [PMID:30684868] [10.1016/j.ejmech.2019.01.032]

Source